Erigeron Breviscapus Extract,China price supplier

Erigeron Breviscapus extract

Latin name: Bergenia purpurascens.

Active ingredients: Breviscapine

CAS NO.: 116122-36-2

Molecular Weight: 908.723

Appearance: Yellow powder

Odor & Taste: Characteristic

Assay(HPLC): Breviscapine 90%,95%

Loss on Drying: ≤ 5.0%

Ignition Residue: ≤ 5.0%

Sieve Analysis: ≥ 100mesh

Extract Solvent: Ethanol

Residual Solvent: ≤ 0.5%

Heavy Metal: ≤ 10ppm

Total Plate Count: <1000cfu/g

yeast & Mold: <100cfu/g

E. Coil: Negative

Salmonella: Negative

Function:

Breviscapine with the expansion of the role of cerebral blood vessels, can reduce cerebral vascular resistance and increase cerebral blood flow, improve microcirculation, and against the role of platelet aggregation. It can be used for the treatment of ischemic cerebrovascular disease, such as cerebral thrombosis, cerebral embolism, cerebral hemorrhage caused by sequelae such as paralyzed patients, with good effect on the course in 6 months or less than the effect of 6 months or more good.

Package: Enterprise standard. Cardboard drum or carton, 25kg/cardboard drum(carton), 2.5kg/bag, double vacuum packing inside.

Storage: Store in cool & dry place. Keep away from strong light and heat.

Grade: Pharmaceutical grade